M&A Deal Summary |
|
|---|---|
| Date | 2010-02-25 |
| Target | Shanghai Zenka Biotechnology |
| Sector | Life Science |
| Buyer(s) | bioMerieux |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1963 |
| Sector | Life Science |
| Employees | 14,147 |
| Revenue | 4.0B EUR (2024) |
bioMerieux is a provider in the field of in vitro diagnostic solutions (reagents, instruments, software) that determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening, monitoring, and cardiovascular emergencies. bioMerieux was founded in 1963 and is based in Marcy-l'Étoile, France.
| DEAL STATS | # |
|---|---|
| Overall | 12 of 21 |
| Sector: Life Science M&A | 8 of 11 |
| Type: Add-on Acquisition M&A Deals | 9 of 17 |
| Country: China M&A | 2 of 3 |
| Year: 2010 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-01-14 |
Meikang Biotech Co.
Shanghai, China Meikang Biotech (Shanghai) Co., Ltd. is a manufacturer of rapid tests products. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-05-19 |
AES Laboratoire Groupe SA
Combourg, France AES Laboratoire Groupe SA is a specialized in industrial microbiological control. |
Buy | €183M |
